cms_DE: 74

In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.

This data as json, copyable

rowid facility_name facility_id address city state zip inspection_date deficiency_tag scope_severity complaint standard eventid inspection_text filedate
74 BRANDYWINE NURSING & REHABILITATION CENTER 85004 505 GREENBANK ROAD WILMINGTON DE 19808 2018-04-25 757 D 1 0 81S611 **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** > Based on clinical record review and interview, it was determined that for one (R7) out of 11 sampled residents, the facility failed to ensure that R7's drug regimen was free from unnecessary drugs, specifically related to inadequate monitoring and inadequate indication for its use. The facility failed to consistently monitor R7's heart rate as per physician ordered parameters from (MONTH) 20, (YEAR) through (MONTH) 19, (YEAR) before administering two anti-hypertensive medications. Findings include: Review of R7's clinical record revealed the following: 2/20/18 - R7 was admitted to the facility with a [DIAGNOSES REDACTED]. 2/20/18 - R7's admission physician orders [REDACTED]. - [MEDICATION NAME] tablet - give 1 tablet daily for hypertension with the parameters to hold the medication for SBP less than 100 and heart rate less than 60; and - [MEDICATION NAME] tablet - give 1 tablet daily for hypertension with the parameters to hold the medication for SBP less than 100 and heart rate less than 60. 2/20/18 to 2/28/18 - Review of R7's (MONTH) (YEAR) eMAR and Progress Notes revealed the following: - [MEDICATION NAME] medication given during the morning medication pass lacked evidence of monitoring R7's heart rate prior to administration on 2 out of 7 days (2/27 and 2/28). - [MEDICATION NAME] medication given during the evening medication pass lacked evidence of monitoring R7's heart rate prior to administration on 3 out of 7 days (2/26, 2/27 and 2/28). 3/1/18 to 3/31/18 - Review of R7's (MONTH) (YEAR) eMAR and Progress Notes revealed the following: - [MEDICATION NAME] medication given during the morning medication pass lacked evidence of monitoring R7's heart rate prior to administration on 29 out of 31 days (3/1 through 3/10, 3/12 through 3/24, and 3/26 through 3/31). - [MEDICATION NAME] medication given during the evening medication pass lacked evidence of monitoring R7's heart rate prior to administration on 29 out of 31 days (3/1 through 3/13, 3/15 through 3/29, and 3/30). 4/1/18 to 4/19/18 - Review of R7's (MONTH) (YEAR) eMAR and Progress Notes revealed the following: - [MEDICATION NAME] medication given during the morning medication pass lacked evidence of monitoring R7's heart rate prior to administration on 17 out of 19 days (4/2 through 4/7, 4/9 through 4/19). - [MEDICATION NAME] medication given during the evening medication pass lacked evidence of monitoring R7's heart rate prior to administration on 6 out of 7 days (4/1 through 4/4, 4/6, 4/7). 4/23/18 at 2:58 PM - During an interview, findings were reviewed and acknowledged with E2 (DON). The facility failed to consistently monitor R7's heart rate as per physician ordered parameters from (MONTH) 20, (YEAR) through (MONTH) 19, (YEAR) before administering two anti-hypertensive medications. 2020-09-01